Pharmaceuticals Market Research Reports & Industry Analysis
The global pharmaceutical industry is a vital part of the healthcare landscape—affecting everyone, from patients seeking treatment to healthcare providers looking for the latest advances in medicine. That's why MarketResearch.com offers a wide range of pharmaceutical reports, providing critical insights into market trends, industry challenges, and emerging opportunities.
What’s Inside Our Pharmaceutical Industry Reports
- We cover an extensive range of segments within the pharmaceutical industry, including biopharmaceuticals, clinical trials, dietary supplements, drug discovery, manufacturing & packaging, over-the-counter drugs, prescription drugs, research & development, vaccines, and more.
- Our research offers valuable information on the market landscape, key factors driving change, company and product profiles, and regulatory analysis.
- We also cover disruptive trends, such as gene editing, precision medicine, and artificial intelligence, ensuring our clients stay ahead of market changes.
MarketResearch.com: A Reliable Source for Critical Data
At MarketResearch.com, we understand the importance of reliable and comprehensive research. For over 20 years, we have been a leading company in the field of market research, bringing together reports from hundreds of leading firms in one place for convenient access.
View recent articles on this industry on our blog:
4 Blockbuster Drugs to Watch for Non-Small Lung Cancer (NSCLC)
Global Prefilled Syringes Market to Achieve Unprecedented Growth by 2035
Global Medical Aesthetic Market to Surge to $102.2 Billion by 2035
Cancer Biomarker Market Size to Reach $39.7 Billion by 2028
Additional articles on this industry
Pharmaceuticals Industry Research & Market Reports
-
Global & Netherlands Cancer Therapeutics Market to 2031
... enhancing cancer treatment and patient outcomes. In September 2024, the Dutch Research Council (NWO) allocated US$ 27.8 million (25 million euros) to tackle the rising challenges in cancer care. With the number of cancer patients ... Read More
-
Global & Peru Cancer Therapeutics Market to 2031
... related deaths were recorded in 2020. The same data also shows that around 4,636 new colorectal cancer cases were diagnosed across all age groups. The rising number of cancer diagnoses is driving demand for effective ... Read More
-
Global & Russia Cancer Therapeutics Market to 2031
... saw over 600,000 new cancer cases in 2023, alongside approximately 300,000 cancer-related deaths. The most common cancers include lung, breast, colorectal, and prostate cancers, with lung cancer posing a major challenge due to high smoking ... Read More
-
Global & Singapore Cancer Therapeutics Market to 2031
... one of the top causes of mortality in the country. As global cancer care evolves, Singapore has emerged as a prominent center for oncology drug development, attracting both domestic and international pharmaceutical companies to conduct ... Read More
-
Global & South Africa Cancer Therapeutics Market to 2031
... component of national expenditure. With both government and private sector investments increasing to enhance healthcare infrastructure, there is a growing demand for therapeutic solutions. As home to one of Africa’s most advanced healthcare systems, South ... Read More
-
Global & Slovakia Cancer Therapeutics Market to 2031
... alcohol consumption stands at 10 liters, exceeding the average across the European Union. Cancer screening rates are also below optimal levels; in 2023-2024, only about 25% of the eligible population underwent breast cancer screening, compared ... Read More
-
Global & United Arab Emirates Cancer Therapeutics Market to 2031
... In the federal budget for 2022, 8.4% of the government’s approved public spending—totaling US$15.8 billion (AED 58.931 billion)—was allocated to the healthcare sector. The UAE government remains the primary financier of its healthcare system and ... Read More
-
Global & United Kingdom Cancer Therapeutics Market to 2031
... by 2040.The emergence of immune checkpoint inhibitors has significantly transformed cancer treatment, offering renewed hope to patients. The UK also hosts Cancer Research UK, the world’s largest independent cancer charity. Each year, the organization allocates ... Read More
-
Global & Ukraine Cancer Therapeutics Market to 2031
... according to the World Health Organization. This figure is expected to rise in the coming years due to an aging population and the increasing prevalence of unhealthy lifestyle habits. As a result, there is a ... Read More
-
Global & United States Cancer Therapeutics Market to 2031
... reach around 2 million. Colorectal cancer ranks as the third most commonly diagnosed cancer among both men and women in the U.S., according to the American Society of Clinical Oncology. In 2023, about 150,000 adults ... Read More
-
Competitor Strategies in Consumer Health
... ensured gradual, broad-based increase of sales over the period of 2019 to 2024. In 2025, industry’s top leaders are focused on the search for efficiencies, be it by divesting their worst-performing brands or leveraging newly ... Read More
-
Global & China Cancer Therapeutics Market to 2031
... diagnoses and 3 million cancer-related deaths were reported in the country in 2020. Alarming statistics from WHO suggest that, on average, seven individuals are diagnosed with cancer every minute in China, and four die from ... Read More
-
Global & Italy Cancer Therapeutics Market to 2031
... cancer being the most frequently diagnosed, accounting for 13.2% of all cases. This was followed by colorectal cancer at 12.6% and lung cancer at 10.0%. That same year, cancer-related deaths reached around 190,000. Contributing to ... Read More
-
Global & Poland Cancer Therapeutics Market to 2031
... the Polish National Cancer Registry reported around 171,558 new cancer diagnoses and 93,652 cancer-related deaths. Additionally, data from the Spanish Network of Cancer Registries indicates that around 8,805 breast cancer deaths occurred in Poland that ... Read More
-
Global & Romania Cancer Therapeutics Market to 2031
... the Romanian Ministry of Health reporting approximately 100,000 new diagnoses each year. The increasing prevalence of risk factors such as tobacco use, unhealthy diets, and an aging population continues to drive cancer incidence rates, thereby ... Read More
-
Global & Philippines Cancer Therapeutics Market to 2031
... and the Philippine Health Insurance Corporation (PhilHealth), have significantly contributed to enhancing access to cancer care services and medications. Despite these advancements, challenges persist—particularly the high cost of therapies and limitations within the country’s healthcare ... Read More
-
Global & Austria Cancer Therapeutics Market to 2031
... around 50,000 annual cases by 2030. By that same year, the total number of individuals living with cancer in the country is projected to reach 460,000—an increase of 15% compared to 2022. The most frequently ... Read More
-
Global & Brazil Cancer Therapeutics Market to 2031
... of the population. This number is projected to increase to nearly 50 million by 2030, representing 24% of the total population. With a steadily aging population, Brazil is witnessing a surge in cancer incidence, particularly ... Read More
-
Global & Germany Cancer Therapeutics Market to 2031
... Organization (WHO) indicates that in 2022, Germany registered approximately 630,000 new cancer cases and around 250,000 cancer-related deaths. This growing burden is driving a strong demand for more effective treatment options. Germany is also recognized ... Read More
-
Global & Qatar Cancer Therapeutics Market to 2031
... The increasing number of cancer diagnoses has led to greater emphasis on advanced treatment options, including immunotherapy and targeted therapies. Healthcare is a priority for Qatar’s government under its National Vision 2030, which aims to ... Read More
-
Global & Sweden Cancer Therapeutics Market to 2031
... role in developing cutting-edge immuno-oncology therapies targeting cancers such as lung and bladder cancer. The Swedish government has taken proactive steps to strengthen its oncology sector through comprehensive national strategies. One such initiative, the Cancer ... Read More
-
Global & Taiwan Cancer Therapeutics Market to 2031
... in managing conditions such as non-small cell lung cancer (NSCLC), melanoma, and head and neck cancers. Additionally, the growing trend toward personalized therapies tailored to patients' genetic profiles has fueled demand for companion diagnostics and ... Read More
-
Global & India Cancer Therapeutics Market to 2031
... cancer, lung cancer, leukemia, and non-Hodgkin lymphoma are among the most frequently observed types. Specifically, breast cancer accounted for 13.5% (178,361) of all cancer cases and 10.6% (90,408) of cancer-related deaths, with a cumulative risk ... Read More
-
Global Pharmacy Automation Market - Focused Insights 2021-2030
... for health systems, provider groups, and federally qualified health centers (FQHCs), to expand its advanced services portfolio. In 2022, BD acquired Parata Systems for USD 1.5 billion to expand its pharmacy automation solutions, enhance patient ... Read More
-
Global Liquid Handling Systems Market - Focused Insights 2021-2030
... over 28%. By Method: The manual segment shows the highest growth of 8.75% during the forecast period. By Application: The drug discovery & development segment holds the largest market share. By End-User: In 2024, the ... Read More
Research Assistance
